Phase I study of CAL-101, an isoform-selective inhibitor of phosphatidylinositol 3‐kinase P110d, in patients with previously treated chronic lymphocytic leukemia
Coutre, S. E., Byrd, J. C., Furman, R. R., Brown, J. R., Benson, D. M., Wagner-Johnston, N. D., Flinn, I. W., Kahl, B. S., Spurgeon, S. E. F., Lannutti, B. J., Hsu, H. K. W., Ulrich, R., Peterman, S., Holes, L., Miller, L. L., Yu, A. S.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article